IQVIA Holdings Inc. (IQV) Valuation
Historical valuation analysis based on 1279 data points (2021-09-14 to 2026-10-16)
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services...
IQVIA Holdings Inc. (IQV) currently trades at a P/E ratio of 31.95 (historical range: 18.22–84.21, median: 32.06), placing it at the 50th percentile — near its historical average, P/S ratio of 2.59 (range: 1.57–4.07, 44th percentile — near its historical average), EV/EBITDA of 25.31 (range: 16.21–55.57, 42th percentile).
Over the historical period (2021-09-14 to 2026-10-16), IQVIA Holdings Inc.'s P/E ratio has contracted by 37% over the observed period (from an average of 42.3 to 26.8).
IQVIA Holdings Inc. trades near its historical valuation range, with most metrics close to their median levels.
Historical Valuation Metrics
| Metric | Current | Median | %ile | Assessment |
|---|---|---|---|---|
| P/E Ratio | 31.95 | 32.06 | 50th | near its historical average |
| P/S Ratio | 2.59 | 2.65 | 44th | near its historical average |
| EV/EBITDA | 25.31 | 26.29 | 42th | near its historical average |
| FCF Yield | 4.97% | 4.69% | 58th | near its historical average |
IQVIA Holdings Inc. (IQV) Valuation & P/E History
IQVIA Holdings Inc. (IQV) is a US-listed stock operating in the Healthcare sector, specifically the Services-Commercial Physical & Biological Research industry currently trading at $266.90 with a market capitalization of $43.9 billion. This page provides historical valuation analysis for IQV based on 1279 data points covering 2021-09-14 to 2026-10-16. The P/E ratio of 31.95 is below the historical median of 32.06, placing IQV at the 50th percentile of its valuation range. The P/S ratio of 2.59 compares to a median of 2.65.
IQV Valuation Metrics & Historical Range
The valuation table above shows IQVIA Holdings Inc.'s current and historical valuation multiples, including P/E ratio, P/S ratio, EV/EBITDA, FCF yield, and dividend yield. Each metric is compared to its own historical range to determine whether IQV is currently trading above or below its typical valuation levels.
- P/E ratio: Price-to-earnings measures how much investors pay per dollar of earnings. A P/E above the historical median suggests IQV is expensively valued; below the median suggests it is cheap.
- P/S ratio: Price-to-sales is useful for companies with volatile or negative earnings. Lower P/S relative to history may indicate value.
- EV/EBITDA: Enterprise value to EBITDA adjusts for debt and cash, providing a capital-structure-neutral valuation measure for IQVIA Holdings Inc..
- FCF yield: Free cash flow yield shows the cash return relative to market price. Higher yields may indicate undervaluation.
Is IQV Overvalued or Undervalued?
IQVIA Holdings Inc. trades near its historical valuation range, with most metrics close to their median levels. The overall valuation percentile of 45 combines P/E, P/S, and EV/EBITDA percentiles into a single measure of how expensive IQV is relative to its own history. A percentile below 25 suggests the stock may be undervalued, while a percentile above 75 suggests it may be overvalued.
However, valuation is only one factor in investment decisions. A stock can remain "overvalued" for years if growth accelerates, or "undervalued" if the business deteriorates. Always combine valuation analysis with financial statement analysis and the full IQV analysis page for a complete picture.
Valuation data is computed from historical price and fundamental data via Polygon.io and Finnhub.IQV trades on NYSE/NASDAQ. This page is for informational purposes only and is not financial advice.